Xanthone Impurity 12
|
4-[(1R)-1,5-Dimethyl-4-hexen-1-yl]-2-cyclohexen-1-one
|
196193-23-4
|
Xanthone Impurity 11
|
4-[(1R)-1,5-Dimethyl-4-hexen-1-yl]-6-hydroxy-2-cycloehexen-1-one
|
915235-16-4
|
Uric Acid Impurity 1
|
5-对硝基苯基糠醛
|
7147-77-5
|
Uric Acid-13C-15N2
|
丹曲林杂质B
|
57268-33-4
|
Uric Acid
|
丹曲林杂质A
|
301359-05-7
|
Indomethacin Impurity 19
|
(2R,3S)-2-羟甲基-2,3-二氢呋喃-3-醇
|
96761-00-1
|
Regorafenib Impurity 82
|
达福普汀
|
112362-50-2
|
Dacarbazine-d6
|
旦著能
|
7261-97-4
|
Isosulfan Blue
|
3-chloroallyl alcohol
|
29560-84-7
|
Debrisoquine Impurity 5
|
rac Xanthoanthrafil-d3
|
1216710-83-6
|
Dantrolene Impurity 12
|
Tiletamine-d5 Hydrochloride
|
1246818-12-1
|
Dantrolene Impurity 11 (5-Hydroxy Dantrolene)
|
达洛鲁胺杂质4
|
2407645-49-0
|
Xanthoanthrafil
|
(5-氨基戊基)(苯基甲氧基)氨基甲酸叔丁酯
|
129245-21-2
|
Dasabuvir Impurity 2
|
8-O-Benzyl Debrisoquin Sulfate
|
1346604-07-6
|
Dasabuvir
|
8-Hydroxy Debrisoquin
|
46286-45-7
|
Deferiprone Impurity 3
|
去铁铵
|
138-14-7
|
Debrisoquine Hemisulfate-13C
|
去铁酮
|
30652-11-0
|
Xanthone Impurity 5
|
Β-鹅膏毒肽
|
21150-22-1
|
Xanthone Impurity 4
|
|
1065274-12-5
|
Deferoxamine Impurity 2
|
氯前列醇杂质5 (DL-氯前列醇钠盐)
|
55028-72-3
|
Deferoxamine Impurity 4
|
占吨酮
|
90-47-1
|
Deferoxamine Impurity 3
|
XANTHOFULVIN
|
151466-15-8
|
Deferoxamine Mesylate
|
[5-[(Phenylmethoxy)amino]pentyl]-carbamic Acid 1,1-Dimethylethyl Ester
|
153492-09-2
|
Xanthone Impurity 10
|
5-[(1R)-1,5-Dimethyl-4-hexen-1-yl]-2-methyl-3-cyclohexene-1,1-diol
|
915301-61-0
|
Brivaracetam Impurity 81
|
达卡巴嗪-D6
|
1185241-28-4
|
Darolutamide-d6
|
1-(3-叔丁基-5-碘-4-甲氧基苯基)嘧啶-2,4(1H,3H)-二酮
|
1132940-53-4
|
Deferiprone-d3
|
(R)-SLV 319
|
656827-86-0
|
Darolutamide Impurity 2
|
Debrisoquin-13C,15N2 Hemisulfate
|
1246814-89-0
|
Darolutamide Impurity 3
|
rac 4-Hydroxydebrisoquine Hemisulfate
|
62580-84-1
|
Darolutamide Impurity 4
|
5-Hydroxy Debrisoquin
|
70746-05-3
|
Tiletamine HCl
|
6-Hydroxy Debrisoquin
|
61911-79-3
|
Tiletamine-d5 Hydrochloride
|
|
70746-06-4
|
Dantrolene
|
1-AMino-5-hydroxyhydantonin
|
42839-65-6
|
Dantrolene Impurity 3 (Dantrolene USP RC C)
|
5-羟基丹曲洛林
|
52130-25-3
|
Dantrolene Impurity 2 (Dantrolene USP RC B)
|
5-(3,4-二氯苯基)-2-糠酸
|
54023-01-7
|
Dantrolene Impurity 5
|
N-{[5-(4-NITROPHENYL)FURAN-2-YL]METHYLIDENE}HYDROXYLAMINE
|
19934-32-8
|
Dantrolene Impurity 4
|
5-hydroxy-1-[(E)-[5-(2,3,5,6-tetradeuterio-4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidine-2,4-dione
|
1217225-15-4
|
Xanthone Impurity 9
|
|
97372-51-5
|
Xanthoanthrafil Impurity 2
|
4-[[5-[[(1,1-Dimethylethoxy)carbonyl]amino]pentyl](phenylmethoxy)amino]-4-oxo-butanoic Acid
|
153492-12-7
|
Xanthoanthrafil Impurity 1
|
N-(4-氰基丁基)-N-(苯基甲氧基)氨基甲酸叔丁酯
|
128173-50-2
|
Xanthoanthrafil-d3
|
N-(苄氧基)氨基甲酸叔丁酯
|
79722-21-7
|
Debrisoquine Impurity 1
|
Deferiprone-d3
|
1346601-82-8
|
Debrisoquine Impurity 2
|
3-羟基-2-甲基-4(1H)-吡啶酮
|
17184-19-9
|
Debrisoquine Impurity 3
|
1-甲基-3-(甲基胺)吡咯烷-2-酮
|
1248282-93-0
|
Debrisoquine Impurity 4
|
苯酰胺那非
|
1020251-53-9
|
3-Chloro-2-propen-1-ol (E/Z Mixture)
|
丹曲林钠杂质
|
14663-28-6
|
Decitabine Impurity 30
|
丹曲林钠杂质
|
55227-60-6
|
Dalfopristin
|
丹曲林钠
|
14663-23-1
|
Dacarbazine Impurity 5
|
丹曲林-13C3
|
1185234-99-4
|
Dantrolene Impurity 1 (Dantrolene USP RC A)
|
5-(3-CHLORO-PHENYL)-FURAN-2-CARBOXYLIC ACID
|
41019-44-7
|
Dantrolene-13C3
|
5-(4-CHLORO-3-FLUOROPHENYL)-2-FUROIC ACID
|
893734-58-2
|
Darolutamide
|
达塞布韦
|
1132935-63-7
|
Darolutamide Impurity 1
|
硫酸异喹胍
|
581-88-4
|
Deferiprone
|
(R)-XANTHOANTHRAFIL
|
247568-68-9
|
Dapagliflozin Impurity 8 Propanediol Monohydrate
|
|
247567-47-1
|
Debrisoquine Impurity 6
|
N-(3,4-DiMethoxybenzyl)-2-fluoro-5-nitrobenzaMide
|
247568-67-8
|
Xanthone Impurity 1 (Xanthone Triflate)
|
|
1119156-19-2
|
Xanthone
|
|
1119156-22-7
|
Xanthofulvin
|
|
1119156-28-3
|
Cloprostenol Impurity 5 (DL-Cloprostenol Sodium Salt)
|
|
1119156-42-1
|
Deferoxamine Impurity 9
|
|
1119156-33-0
|
Deferoxamine Impurity 7
|
5-bromo-3,4-dimethyl-9H-xanthen-9-one
|
1035912-43-6
|
Deferoxamine Impurity 6
|
Atroviridin
|
207984-34-7
|
Deferoxamine Impurity 5
|
三羟甲基蒽醌
|
1445772-45-1
|
Xanthone Impurity 8
|
(R)-5-(1,5-二甲基-4-己烯基)-邻甲酚
|
30199-26-9
|
Xanthoanthrafil Impurity 3
|
9,12-Dioxo-21-phenyl-8-(phenylmethoxy)-20-oxa-2,8,13,19-tetraazaheneicosanoic Acid 1,1-Dimethylethyl Ester
|
160388-22-7
|
Ibipinabant Impurity 2
|
N-(苯基甲氧基)-1,5-戊二胺
|
160388-21-6
|
*Carbon tetrabromide
|
p-NCS-Bz-DFO
|
1222468-90-7
|
Ozagrel Impurity 44
|
尿酸杂质1
|
2124-54-1
|
Moxifloxacin Impurity 130
|
达卡巴嗪相关物质B
|
63907-29-9
|
Ozagrel Impurity 43
|
尿酸
|
69-93-2
|
Dantrolene Impurity 6
|
达洛鲁胺
|
1297538-32-9
|
Dantrolene Impurity 7
|
|
2484757-33-5
|
Dantrolene Impurity 8
|
ORM-15341
|
1297537-33-7
|
Dantrolene Impurity 9
|
2-氯-4-(1H-吡唑-3-基)苯甲腈
|
1297537-37-1
|
Dantrolene Impurity 10
|
达洛鲁胺杂质3
|
2415967-06-3
|
Xanthone Impurity 2 (Atroviridin)
|
|
104553-84-6
|
Xanthone Impurity 3
|
|
1119363-28-8
|
Deferoxamine Impurity 8
|
|
1119156-37-4
|
Xanthone Impurity 7
|
叶黄素
|
127-40-2
|
Xanthone Impurity 6
|
3-(4-吗啉)-1-丙醇
|
4441-30-9
|
Etravirine Impurity 13
|
13C2,2H6]-达拉非尼羧酸二锂盐
|
1195873-54-1
|
Etravirine Impurity 14
|
去甲基达拉非尼
|
1195765-47-9
|
Etravirine Impurity 15
|
羟基达拉非尼
|
1195767-77-1
|
Etravirine Impurity 9
|
2,6-二羟基嘌呤
|
69-89-6
|
Evogliptin Tartrate
|
3-溴-2-氟苯甲酸
|
161957-56-8
|
Etravirine Impurity 10
|
Xanthine-13C15N2
|
1262670-81-4
|
Etravirine Impurity 11
|
XANTHINE AMINE CONGENER;XAC
|
96865-92-8
|
Etravirine Impurity 12
|
达帕菲尼杂质
|
1423119-98-5
|
Dabrafenib Impurity 7
|
异硫蓝
|
68238-36-8
|
Dabrafenib Impurity 6
|
4-甲基肉桂酸甲酯
|
88738-86-7
|
Dabrafenib Impurity 5
|
2-甲基肉桂酸
|
2373-76-4
|
Dabrafenib Impurity 4
|
对甲基肉桂酸甲酯
|
20754-20-5
|
Dabrafenib Impurity 3
|
MOXIFLOXACIN RELATED COMPOUND F
|
1179992-99-4
|
Dabrafenib Impurity 8
|
Indomethacin Impurity 2
|
72155-33-0
|
Dabrafenib Impurity 9
|
3-氟-4-硝基苯酚
|
394-41-2
|
Dabrafenib-d9
|
布瓦西坦杂质81
|
774198-33-3
|
Xanthine Impurity 1
|
达拉非尼杂质1
|
1195768-20-7
|
Xanthine-13C-15N2
|
2,2,2-三甲基硫代乙酰胺
|
630-22-8
|
Xanthine
|
2,6-二氟苯磺酰氯
|
60230-36-6
|